Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about GLAXOSMITHKLINE PLC
08/10GLAXOSMITHKLINE : CureVac Sets IPO at 13.3 Million Shares; Sees Pricing at $14-$..
DJ
08/07GLAXOSMITHKLINE : FDA approves GSK's BLENREP for the treatment of patients with ..
AQ
08/06GLAXOSMITHKLINE : FDA approves GSK's BLENREP (belantamab mafodotin-blmf) for the..
AQ
08/05GLAXOSMITHKLINE : U.S. FDA approves GlaxoSmithKline's blood cancer drug
RE
08/05GLAXOSMITHKLINE : FDA approves GSK's BLENREP (belantamab mafodotin-blmf) for the..
PU
08/03GlaxoSmithKline and Sanofi to Supply EU With 300 Million Covid-19 Doses
DJ
07/31EU in talks to secure Sanofi deal for coronavirus vaccine
RE
07/31U.S. to pay $2.1 billion to Sanofi, GSK, in COVID-19 vaccine deal
RE
07/31GLAXOSMITHKLINE : REFILE-Sanofi, Glaxo advance talks to supply up to 300 mln COV..
RE
07/31U.S. to pay $2.1 billion to Sanofi, GSK, in COVID-19 vaccine deal
RE
07/31GLAXOSMITHKLINE : Goldman Sachs gives a Buy rating
MD
07/31GLAXOSMITHKLINE : GSK to share evidence supporting a personalised approach to as..
AQ
07/30GLAXOSMITHKLINE : Credit Suisse gives a Neutral rating
MD
07/29GLAXOSMITHKLINE : JP Morgan gives a Neutral rating
MD
07/29GSK profit misses as vaccine sales disappoint, stockpiling eases
RE
More most relevant news
All news about GLAXOSMITHKLINE PLC
05:05pVir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in Au..
RE
08/10GLAXOSMITHKLINE : CureVac Sets IPO at 13.3 Million Shares; Sees Pricing at $14-$..
DJ
08/10Biotech company CureVac aims to raise up to $245 million in U.S. IPO
RE
08/10Biotech company CureVac aims to raise up to $245 million in U.S. IPO
RE
08/10Biotech company CureVac aims to raise up to $245 mln in U.S. IPO
RE
08/07GLAXOSMITHKLINE : FDA approves GSK's BLENREP for the treatment of patients with ..
AQ
08/06GLAXOSMITHKLINE : FDA approves GSK's BLENREP (belantamab mafodotin-blmf) for the..
AQ
08/05GLAXOSMITHKLINE : U.S. FDA approves GlaxoSmithKline's blood cancer drug
RE
08/05GLAXOSMITHKLINE : FDA approves GSK's BLENREP (belantamab mafodotin-blmf) for the..
PU
08/03FOCUS : Next big COVID-19 treatment may be manufactured antibodies
RE
More news
News in other languages on GLAXOSMITHKLINE PLC
05:05pVir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in Au..
05:39aBAYER : sichert sich mögliches Blockbuster-Medikament
08/10GLAXOSMITHKLINE : CureVac Sets IPO at 13.3 Million Shares; Sees Pricing at $14-$..
08/10Biotech company CureVac aims to raise up to $245 million in U.S. IPO
08/10Biotech company CureVac aims to raise up to $245 million in U.S. IPO
08/10WALL STREET STOCK EXCHANGE : CureVac hofft auf bis zu 245 Mio Dollar bei US-Börs..
08/10CREDIT SUISSE : CureVac quiere captar 245 millones de dólares en su salida a bol..
08/10Biotech company CureVac aims to raise up to $245 mln in U.S. IPO
08/07GLAXOSMITHKLINE : FDA approves GSK's BLENREP for the treatment of patients with ..
08/06Jeff Bezos vend des actions Amazon pour un montant de 3 mds de dollars
Analyst Recommendations on GLAXOSMITHKLINE PLC
07/31GLAXOSMITHKLINE : Goldman Sachs gives a Buy rating
MD
07/30GLAXOSMITHKLINE : Credit Suisse gives a Neutral rating
MD
07/29GLAXOSMITHKLINE : JP Morgan gives a Neutral rating
MD
07/24GLAXOSMITHKLINE : Gets a Neutral rating from JP Morgan
MD
07/16GLAXOSMITHKLINE : Goldman Sachs keeps its Buy rating
MD
More recommendations
Press releases
08/07GLAXOSMITHKLINE : FDA approves GSK's BLENREP for the treatment of patients with ..
AQ
08/06GLAXOSMITHKLINE : FDA approves GSK's BLENREP (belantamab mafodotin-blmf) for the..
AQ
08/05GLAXOSMITHKLINE : FDA approves GSK's BLENREP (belantamab mafodotin-blmf) for the..
PU
07/31GLAXOSMITHKLINE : GSK to share evidence supporting a personalised approach to as..
AQ
07/29GLAXOSMITHKLINE : GSK delivers Q2 sales of £7.6 billion -2% AER, -3% CER (Pro-fo..
PU
More press releases
Upcoming event on GLAXOSMITHKLINE PLC